help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luine, V. N.
Right arrow Articles by McEwen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luine, V. N.
Right arrow Articles by McEwen, B. S.

Endocrinology, Vol 100, 903-910, Copyright © 1977 by Endocrine Society


ARTICLES

Effects of an estrogen antagonist on enzyme activities and [3H]estradiol nuclear binding in uterus, pituitary and brain

VN Luine and BS McEwen

The estrogenic and anti-estrogenic properties of CI-628 on these specific biochemical markers of estrogen action was not identical in the different target tissues. The CI-628 dependent changes in protein content and enzyme activities in the uterus were less than half of the EB changes. In the preoptic area and CM-amygdala, CI-628 resulted in approximately the same changes in CAT and MAO activity as EB. 3) In the pituitary and uterus, CI-628 antagonized the EB-dependent increase in G6PDH activity. In the CM-amygdala and preoptic area, CI-628 pretreatment did not anatagonize the EB dependent changes in CAT and MAO. 4) CI-628 reduced nuclear binding of[3H]estradiol to approximately 5% of control in the uterus and pituitary and this effect lasted for at least 96 h. In contrast, CI-628 reduced nuclear binding in the preoptic area-hypothalamus-amygdala to 13% of control at 18 h after CI-628, but at 96 h nuclear binding of [3H]estradiol had recovered to 70% of control. Thus, the effect of CI-628 ON THESE SPECIFIC BIOCHEMICAL MARKERS OF ESTROGEN ACTION WAS NOT IDENTICAL IN THE DIFFERENT TARGET TISSUES. The possibility is discussed that the basis for the heterogeneity of responses may reside in the different time course of CI-628 interaction with cellular estrogen receptors in the target tissues.or the heterogeneity of responses may reside in the different time course of CI-628 interaction with cellular estrogen receptors in the target tissues.


This article has been cited by other articles:


Home page
Recent Prog Horm ResHome page
B. McEwen
Estrogen Actions Throughout the Brain
Recent Prog. Horm. Res., January 1, 2002; 57(1): 357 - 384.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. S. McEwen and S. E. Alves
Estrogen Actions in the Central Nervous System
Endocr. Rev., June 1, 1999; 20(3): 279 - 307.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. S. McEwen
The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1790 - 1797.
[Full Text]


Home page
EndocrinologyHome page
B. S. McEwen, P. Tanapat, and N. G. Weiland
Inhibition of Dendritic Spine Induction on Hippocampal CA1 Pyramidal Neurons by a Nonsteroidal Estrogen Antagonist in Female Rats
Endocrinology, March 1, 1999; 140(3): 1044 - 1047.
[Abstract] [Full Text]


Home page
ScienceHome page
B. McEwen
Neural gonadal steroid actions
Science, March 20, 1981; 211(4488): 1303 - 1311.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society